Whistleblower News from the Inside - June 18, 2013

More evidence of meat-diabetes link – An analysis of several studies funded by the National Institutes of Health and published in the JAMA Internal Medicine journal provides further support for a direct link between red-meat consumption and the development of Type 2 diabetes.  WSJ

Supreme Court rules against drug makers on pay-for-delay arrangements – It is a common tactic by brand name drug manufactures to settle patent challenges brought by their generic rivals.  Pay them to go away and delay their entry into the market until the brand-name patent expires.  The Supreme Court in a 5-3 decision just ruled that these deals could violate the antitrust laws.  NYT, LA Times

Walgreen’s slapped with heavy DEA fine over sale of painkillers – The nation’s largest drug store chain was hit with an $80 million fine for failing to comply with U.S. Drug Enforcement Agency’s rules on the sale of prescription painkillers like Oxycodone, Hydrocodone and Xanax.  Boston Globe

SEC makes second whistleblower award – In what many see as the second drop of the soon to be opened floodgate of whistleblower payments, the SEC just gave out its second-ever award under the whistleblower program established by the Dodd-Frank financial overhaul law.  WSJ

SAIC fined for overcharging government to train first responders – Science Applications International Corp. paid $11.75 million to settle government charges that it violated the False Claims Act by inflating the prices it charged under a government program to train first responder personnel to prevent and respond to terrorist attacks.  DOJ